SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-22-052233
Filing Date
2022-02-24
Accepted
2022-02-24 16:46:34
Documents
12
Period of Report
2022-02-17
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

Document Format Files

Seq Description Document Type Size
1 8-K d312370d8k.htm   iXBRL 8-K 24254
  Complete submission text file 0001193125-22-052233.txt   145351

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA zgnx-20220217.xsd EX-101.SCH 2857
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE zgnx-20220217_lab.xml EX-101.LAB 17995
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE zgnx-20220217_pre.xml EX-101.PRE 11262
6 EXTRACTED XBRL INSTANCE DOCUMENT d312370d8k_htm.xml XML 3343
Mailing Address 5959 HORTON STREET, SUITE 500 EMERYVILLE CA 94608
Business Address 5959 HORTON STREET, SUITE 500 EMERYVILLE CA 94608 (510) 550-8300
ZOGENIX, INC. (Filer) CIK: 0001375151 (see all company filings)

IRS No.: 205300780 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-34962 | Film No.: 22671887
SIC: 2834 Pharmaceutical Preparations